{"id":2330807,"date":"2024-08-26T06:07:02","date_gmt":"2024-08-26T10:07:02","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/lawmakers-pharma-might-be-experimenting-on-chinese-slaves\/"},"modified":"2024-08-26T06:11:59","modified_gmt":"2024-08-26T10:11:59","slug":"lawmakers-pharma-might-be-experimenting-on-chinese-slaves","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/lawmakers-pharma-might-be-experimenting-on-chinese-slaves\/","title":{"rendered":"Lawmakers: Pharma Might Be Experimenting On Chinese Slaves"},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"&quot;\"><div class=\"counts mashsbcount\">16<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Flawmakers-pharma-might-be-experimenting-on-chinese-slaves%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2330807&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><p>A bipartisan group of House lawmakers\u2063 is urging the FDA to investigate U.S. biopharmaceutical companies conducting clinical trials \u2064in Xinjiang, China, where the\u200b Uyghur population faces severe persecution by the Chinese Communist Party (CCP). The lawmakers, led by John Moolenaar and Raja Krishnamoorthi, expressed concerns over national security, data\u200d integrity, and human rights violations. They highlighted that many clinical trials involved entities linked to the People\u2019s Liberation Army (PLA), raising fears of <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/senior-partners-at-firm-hired-to-review-lincoln-project-scandal-have-donated-thousands-to-group\/\" title=\"Senior Partners at Firm Hired to \u2018Review\u2019 Lincoln Project Scandal Have Donated Thousands to Group\">intellectual property theft<\/a> and compromising U.S. competitiveness. Additionally,\u200c the reliability of <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/u-s-plans-to-send-astrazeneca-vaccines-to-mexico-canada\/\" title=\"U.S. Plans To Send AstraZeneca Vaccines To Mexico, Canada\">clinical trial data<\/a> from China is questioned, as vast amounts have been\u200d found to be fabricated,\u2062 posing risks to American patients. Trials conducted in Xinjiang are particularly troubling, given the region&#8217;s history of ethnic cleansing and human rights abuses against \u200dUyghurs. The lawmakers believe U.S. companies might\u200c unknowingly \u2062benefit from unethical data derived from trials involving coerced \u2064participation. They have set \u200ca deadline for the FDA to address these issues and urge greater oversight to protect U.S. national \u2062security interests.  <\/p>\n<p class=\"readmore\">\n    <button onclick=\"showReadMore()\" id=\"readmorebtn\">Read more&#8230;<\/button>\n<\/p>\n<hr id=\"line\">\n<span id=\"more\"><\/p>\n<div>\n<p>A group of House lawmakers has urgently called upon the Food and Drug Administration (FDA) to investigate American biopharmaceutical companies that <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/moderna-asks-fda-to-authorize-second-booster-for-covid\/\" title=\"Moderna Asks FDA to Authorize Second Booster for COVID\">conducted clinical trials<\/a> in Xinjiang, China, where millions of Uyghurs and other ethnic minorities have faced persecution by the Chinese Communist Party (CCP).&nbsp;<\/p>\n<p>The group of bipartisan representatives, led by House Select Committee on the CCP Chairman John Moolenaar, R-Mich., and the committee&rsquo;s ranking member, Raja Krishnamoorthi, D-Ill., sent a <a href=\"https:\/\/cdn.sanity.io\/files\/ifn0l6bs\/production\/616eae60ca3023b42ec45074085ad38bcea7d257.pdf\">letter<\/a> to FDA Commissioner Robert Califf last Monday. The letter pointed out that based on publicly available data, major U.S. biopharmaceutical companies have conducted hundreds of clinical trials in China for at least 10 years, a practice that raises three primary concerns: national security, data integrity, and human rights violations.<\/p>\n<p>First, most of these clinical trials involved at least one entity associated with the People&rsquo;s Liberation Army (PLA). For example, the lawmakers wrote that one American biopharmaceutical company conducted a cancer therapeutic clinical trial at the 307 Hospital, controlled and operated by the PLA&rsquo;s Academy of Military Medical Sciences (AMMS). Notably, the U.S. government has blacklisted AMMS on the U.S. Department of Commerce&rsquo;s Entity List due to national security concerns. <\/p>\n<p>The lawmakers are deeply concerned that the involvement of PLA entities in clinical trials poses a significant risk of either &ldquo;critical Intellectual Property (IP) being transferred to the PLA or being co-opted under the People&rsquo;s Republic of China&rsquo;s (PRC).&rdquo; Essentially, these U.S. companies have undermined their own competitiveness and endangered national security by partnering with the PLA-affiliated entities.<\/p>\n<p>Second, clinical trial data from China is notoriously unreliable. An investigation in China <a href=\"https:\/\/www.rfa.org\/english\/news\/china\/clinical-fakes-09272016141438.html\">revealed<\/a> that fraudulent&nbsp;practices in clinic trials were widespread, with a staggering 80 percent of data being fabricated. This poses a significant risk to American patients, as biopharmaceutical companies that rely on such data may inadvertently develop or fine-tune health-care products and services that could harm rather than help. <\/p>\n<p>The FDA&rsquo;s previous decisions to decline treatments based solely on Chinese clinical trial data underscore the gravity of this issue. Therefore, these U.S. lawmakers suggest that the FDA should impose similar scrutiny on clinical trial work done in cooperation with the PLA, a measure that could provide much-needed reassurance to the public.<\/p>\n<p>Third, it is disturbing that some of the clinical trials were set in hospitals located in Xinjiang (XUAR), where the Uyghur Muslim population and other ethnic minorities in the region have been subjected to the CCP&rsquo;s brutal, government-led, systematic ethnic cleansing for at least a decade. <\/p>\n<p>Uyghur Muslims&rsquo; religious sites and cultural heritage have been <a href=\"https:\/\/www.theguardian.com\/world\/2020\/sep\/25\/thousands-of-xinjiang-mosques-destroyed-damaged-china-report-finds\" target=\"_blank\" rel=\"noreferrer noopener\">bulldozed and erased<\/a>. More than 1 million Uyghur Muslims and other minorities (the majority of whom have committed no crimes) were subjected to <a href=\"https:\/\/www.theguardian.com\/world\/2020\/sep\/24\/china-has-built-380-internment-camps-in-xinjiang-study-finds\" target=\"_blank\" rel=\"noreferrer noopener\">mass incarceration<\/a>. A new <a href=\"https:\/\/gsp.yale.edu\/uyghur-race-enemy-chinas-legalized-authoritarian-oppression-and-mass-imprisonment\" target=\"_blank\" rel=\"noreferrer noopener\">report<\/a> by Yale University estimates that the Uyghur Muslim population in China is collectively facing a cumulative 4.4 million years of imprisonment as the result of the Communist Party&rsquo;s legalized repression.&nbsp;<\/p>\n<p>After erasing the Uyghurs&rsquo; cultural and ethnic identity, destroying their homeland, and separating families and loved ones, the CCP still wants to squeeze out the last drop of the economic value of every Uyghur Muslim. Those who &ldquo;survived&rdquo; internment camps still cannot get their freedom and dignity back. Some were <a href=\"https:\/\/www.aspi.org.au\/report\/uyghurs-sale\" target=\"_blank\" rel=\"noreferrer noopener\">reportedly<\/a> transferred to various factories inside and outside Xinjiang as forced laborers. <\/p>\n<p>Ethan Gutmann, a research fellow at the Victims of Communism Memorial Foundation, <a href=\"https:\/\/www.rfa.org\/english\/news\/uyghur\/forced-organ-harvesting-03202024133851.html\" target=\"_blank\" rel=\"noreferrer noopener\">testified in<\/a> March this year at a congressional hearing that Chinese medical authorities, in the words of Radio Free Asia, &ldquo;are collecting genetic data from the country&rsquo;s Muslim Uyghur minority as part of a forced organ-transplant program marketed to Muslim medical tourists from Gulf states.&rdquo; <\/p>\n<p>This troubling evidence suggests that Uyghurs do not have bodily autonomy under the iron fist of the CCP. U.S. lawmakers argue that U.S. companies &ldquo;could be unintentionally profiting from the data derived from clinical trials during which the CCP forced victim patients to participate.&rdquo; The profound ethical implications of such involvement cannot be ignored.<\/p>\n<p>These concerns have prompted urgent action from lawmakers, who have called on the FDA to &ldquo;take on a greater role in protecting U.S. national security interests.&rdquo; They have set a deadline of Oct. 1 for the agency to provide answers to a list of questions, including the number of FDA-reviewed clinical trial works that involved PLA-owned, operated, or affiliated facilities and whether the agency has ever notified any U.S. biopharmaceutical organization that it has conducted studies with the PLA or in the XUAR.<\/p>\n<p>While the lawmakers&rsquo; letter was addressed to the FDA, U.S. biopharmaceutical companies should take it as a warning as the lawmakers reminded these companies that &ldquo;the United States is engaged in a fierce competition with the People&rsquo;s Republic of China (PRC) in biotechnology. This competition will not only have implications for our national and economic security, but also for the future of healthcare and the security of American medical data.&rdquo;<\/p>\n<p>The potential harm to our national and economic security is a matter of grave concern, and it is both appalling and shortsighted that U.S. biomedical companies continue to work with PLA entities and profit from the Uyghur Muslims&rsquo; suffering. If these companies genuinely strive for scientific integrity, care about saving lives, and are willing to stand up for human rights, they must now end these clinical trials in China. &nbsp;&nbsp;<\/p>\n<hr>\n<div>\n<p>      Helen Raleigh, CFA, is an American entrepreneur, writer, and speaker. She&#8217;s a senior contributor at The Federalist. Her writings appear in other national media, including The Wall Street Journal and Fox News.  Helen is the author of several books, including &#8220;<a href=\"https:\/\/www.amazon.com\/Confucius-Never-Said-Helen-Raleigh\/dp\/1499185278\/ref=sr_1_1?dchild=1&amp;keywords=Helen+Raleigh+Confucius+Never+Said&amp;qid=1606079469&amp;sr=8-1\">Confucius Never Said<\/a>&#8221; and &ldquo;<a href=\"https:\/\/www.amazon.com\/Backlash-How-Chinas-Aggression-Backfired\/dp\/1736008501\/ref=tmm_pap_swatch_0?_encoding=UTF8&amp;qid=1606006113&amp;sr=8-1\">Backlash: How Communist China&#8217;s Aggression Has Backfired<\/a>.&#8221; Her latest book is the 2nd edition of <a href=\"https:\/\/www.amazon.com\/Broken-Welcome-Mat-unAmerican-immigration-ebook\/dp\/B0C44QSPJ9\/ref=sr_1_3?crid=3HFXEVT236ZRW&amp;keywords=The+Broken+welcome+mat+book&amp;qid=1683127487&amp;sprefix=the+broken+welcome+mat+book%2Caps%2C135&amp;sr=8-3\">&ldquo;The Broken Welcome Mat: America&rsquo;s UnAmerican immigration policy, and how we should fix it.&rdquo;<\/a>   Follow her on Parler and Twitter: @HRaleighspeaks.<\/p>\n<\/div><\/div>\n<p><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A bipartisan group of House lawmakers has urgently requested that the Food and Drug Administration (FDA) look into American biopharmaceutical companies that have carried out clinical trials in Xinjiang, China, where the Chinese Communist Party (CCP) has persecuted millions of Uyghurs and other ethnic minorities. The representatives, led by John Moolenaar, R-Mich., chairman of the House Select Committee on the CCP, and ranking member Raja Krishnamoorthi, D-Ill., sent a letter to FDA Commissioner Robert Califf last Monday. They highlighted that major U.S. biopharmaceutical firms have been conducting hundreds of clinical trials in China for over a decade based on publicly available information. This raises three main concerns: national security risks, data integrity issues, and human rights violations.<\/p>\n<p>Firstly, many of these trials involved entities linked to the People\u2019s Liberation Army (PLA). For instance, one U.S. company conducted a cancer treatment trial at a hospital managed by the PLA\u2019s Academy of Military Medical Sciences (AMMS), which is blacklisted by the U.S. government due to national security issues. The lawmakers expressed alarm that collaboration with PLA-affiliated organizations could lead to critical intellectual property being transferred or compromised under Chinese control.<\/p>\n<p>Secondly, there are significant doubts about the reliability of clinical trial data from China; investigations revealed widespread fraudulent practices with around 80% of data being fabricated. This poses serious risks for American patients if biopharmaceutical companies base their products on such unreliable information.<\/p>\n<p>Thirdly, it is troubling that some trials took place in hospitals within Xinjiang\u2014an area where Uyghur Muslims and other ethnic minorities have endured systematic persecution by the CCP for over ten years. Reports indicate extensive cultural erasure and mass incarceration affecting more than one million individuals who have committed no crimes.<\/p>\n<p>Ethan Gutmann from the Victims of Communism Memorial Foundation testified earlier this year about allegations regarding forced organ transplants involving genetic data collection from Uyghurs as part of a program targeting Muslim medical tourists from Gulf states.<\/p>\n<p>These alarming findings suggest that Uyghurs lack bodily autonomy under CCP rule while raising ethical concerns about potential profits made by U.S. companies from coerced participation in clinical trials involving victimized patients.<\/p>\n<p>In light of these issues, lawmakers are urging greater FDA oversight to protect U.S. national security interests and set an October 1 deadline for answers regarding FDA-reviewed clinical trials associated with PLA facilities or operations in Xinjiang.<\/p>\n<p>While directed at the FDA, this letter serves as a warning to U.S.-based biopharmaceutical firms amid fierce competition with China in biotechnology\u2014a rivalry impacting both national security and healthcare futures along with American medical data safety.<\/p>\n<p>The ongoing collaboration between U.S biomedical companies and PLA entities amidst such severe human rights abuses is both concerning and shortsighted; if these firms genuinely value scientific integrity and human rights advocacy they must cease all clinical trial activities in China immediately<\/p>\n","protected":false},"author":536,"featured_media":2330808,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/thefederalist.com\/wp-content\/uploads\/2024\/08\/Stand-for-Uyghurs-Melbourne-rally.jpg","fifu_image_alt":"","footnotes":""},"categories":[],"tags":[11959,4501,29312,36866,39259],"class_list":["post-2330807","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-pharma","tag-china","tag-experimentation","tag-humanrights","tag-lawmaking"],"fifu_image_url":"https:\/\/thefederalist.com\/wp-content\/uploads\/2024\/08\/Stand-for-Uyghurs-Melbourne-rally.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2330807","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/536"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2330807"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2330807\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2330808"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2330807"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2330807"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2330807"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}